The results demonstrate that resveratrol treatment of T2DM mice increased nuclear SIRT1 content also in the liver, which was previously observed in insulin-treated T1DM rat, is also accompanied by a reduction in Slc2a2 gene expression [43]. The gene discussed is SIRT1; the disease is type 1 diabetes mellitus.